{"id":"W2326643498","doi":"10.1056/nejmoa1503824","title":"Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":806,"is_retracted":false,"has_abstract":true,"ca_institutions":"XLV Diagnostics (Canada); Dalhousie University; Probity Medical Research","funders":"","keywords":"Medicine; Ustekinumab; Psoriasis; Dermatology; Ixekizumab; Internal medicine; Secukinumab; Psoriatic arthritis; Disease; Infliximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008658749,0.000167633,0.0006830383,0.000251312,0.000040411,0.000004001442,0.0001409649,0.0000729762,0.00006043406],"category_scores_gemma":[0.0002672133,0.00009455631,0.0000400478,0.00018814,0.0001332998,0.00009817274,0.00002047653,0.0002392634,0.00001693253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008716136,"about_ca_system_score_gemma":0.0001536068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001279466,"about_ca_topic_score_gemma":0.0002784466,"domain_scores_codex":[0.998889,0.0002098458,0.0004616051,0.0001219645,0.0001021832,0.000215364],"domain_scores_gemma":[0.9991025,0.0002116407,0.0002832692,0.0001269129,0.0001921188,0.00008357081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0208799,0.001102214,0.06959794,0.00004671629,0.002693916,0.001284757,0.02677189,0.0001688512,0.009233616,0.000226629,0.03412835,0.8338652],"study_design_scores_gemma":[0.845829,0.01573716,0.007121796,0.001210466,0.001201761,0.005541698,0.009994206,0.000008478719,0.006849364,0.0007928218,0.1053467,0.0003665164],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9678658,0.02834935,0.00008125661,0.001276027,0.001500413,0.00008318928,0.00000147175,0.00001081482,0.0008317068],"genre_scores_gemma":[0.9975757,0.0005871814,0.0001851023,0.00007276778,0.0009059533,0.000001655187,0.000008376014,0.00001049165,0.0006527458],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8334987,"threshold_uncertainty_score":0.3855895,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07908791848008138,"score_gpt":0.3240991282479725,"score_spread":0.2450112097678911,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}